ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,763.90
-0.07%
S&P ASX All Technology
3,069.70
-0.63%
Brent Oil
84.505
-0.22%
US Dollar vs AUD
1.49901
0.06%
Bitcoin
65,256.11
0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mangoceuticals Inc (MGRX)

  7. Mangoceuticals Inc (MGRX) News

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGRX
DateTimeSourceHeadlineSymbolCompany
19/06/202404:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
11/06/202403:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/06/202422:30GlobeNewswire Inc.MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyNASDAQ:MGRXMangoceuticals Inc
06/06/202407:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
06/06/202407:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
06/06/202407:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
05/06/202406:00GlobeNewswire Inc.MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont TechnologiesNASDAQ:MGRXMangoceuticals Inc
04/06/202422:00GlobeNewswire Inc.MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone ImbalancesNASDAQ:MGRXMangoceuticals Inc
28/05/202422:30GlobeNewswire Inc.Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American MarketsNASDAQ:MGRXMangoceuticals Inc
23/05/202422:30GlobeNewswire Inc.MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing EffortsNASDAQ:MGRXMangoceuticals Inc
21/05/202422:30GlobeNewswire Inc.MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 MedicationsNASDAQ:MGRXMangoceuticals Inc
17/05/202406:40GlobeNewswire Inc.MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market PenetrationNASDAQ:MGRXMangoceuticals Inc
17/05/202403:59Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGRXMangoceuticals Inc
16/05/202423:19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGRXMangoceuticals Inc
16/05/202406:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGRXMangoceuticals Inc
14/05/202423:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGRXMangoceuticals Inc
10/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGRXMangoceuticals Inc
07/05/202407:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGRXMangoceuticals Inc
07/05/202406:43Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MGRXMangoceuticals Inc
02/05/202422:00GlobeNewswire Inc.Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity RequirementNASDAQ:MGRXMangoceuticals Inc
25/04/202422:30GlobeNewswire Inc.Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareNASDAQ:MGRXMangoceuticals Inc
12/04/202422:45GlobeNewswire Inc.Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsNASDAQ:MGRXMangoceuticals Inc
13/03/202400:00GlobeNewswire Inc.MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) TreatmentNASDAQ:MGRXMangoceuticals Inc
21/02/202401:00GlobeNewswire Inc.MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue GrowthNASDAQ:MGRXMangoceuticals Inc
14/02/202400:00GlobeNewswire Inc.MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITYNASDAQ:MGRXMangoceuticals Inc
07/02/202401:00GlobeNewswire Inc.MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITSNASDAQ:MGRXMangoceuticals Inc
06/02/202400:50GlobeNewswire Inc.MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) ProductNASDAQ:MGRXMangoceuticals Inc
20/01/202400:00GlobeNewswire Inc.MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11NASDAQ:MGRXMangoceuticals Inc
16/12/202302:39GlobeNewswire Inc.Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public OfferingNASDAQ:MGRXMangoceuticals Inc
13/12/202323:30GlobeNewswire Inc.MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCTNASDAQ:MGRXMangoceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MGRX

Your Recent History

AQSE
SGLP.GB
Invesco Physical Markets
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved